Marie Quinn

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

Marco Carbone, Alessandra Nardi, Steve Flack et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 163 citations · Full text

Medicine, Internal Medicine, Hepatology +9

X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

Rosanna Asselta, Elvezia Maria Paraboschi, Alessio Gerussi et al. · Gastroenterology · 2021 · 52 citations · Full text

Medicine, Genetics, Molecular Genetics +13

Phase 1, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Intravenous Alvespimycin (KOS-1022) in Patients with Refractory Hematological Malignancies.

Jeffrey E. Lancet, Maria R. Baer, Ivana Gojo et al. · Blood · 2006 · 17 citations

Medicine, Pharmacokinetics, Pharmacology +11

Atypical Ductal Hyperplasia and Those Bordering on Ductal Carcinoma In Situ Should Be Included in the Active Surveillance Clinical Trials

Thaer Khoury, Nashwan Jabbour, Xuan Peng et al. · American Journal of Clinical Pathology · 2019 · 12 citations · Full text

Medicine, Oncology, Pathology +14

Touching tumour‐infiltrating lymphocytes in low‐risk ductal carcinoma <i>in situ</i> (DCIS) correlate with upgrading to high‐grade DCIS

Thaer Khoury, Marie Quinn, Wanqing Tian et al. · Histopathology · 2021 · 12 citations

Medicine, Oncology, Pathology +17